<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">OXAZEPAM</span><br/>(ox-a'ze-pam)<br/><span class="topboxtradename">Ox-Pam <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Serax, </span><span class="topboxtradename">Zapex <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">anxiolytic</span>; <span class="classification">sedative-hypnotic</span>; <span class="classification">benzodiazepine</span><br/><b>Prototype: </b>Lorazepam<br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg, 15 mg, 30 mg capsules; 15 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Benzodiazepine derivative related to lorazepam. Effects are mediated by the inhibitory neurotransmitter GABA. Acts on the
         thalamic, hypothalamic, and limbic levels of CNS.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Has anxiolytic, sedative, hypnotic, and skeletal muscle relaxant effects.</p>
<h1><a name="uses">Uses</a></h1>
<p>Management of anxiety and tension associated with a wide range of emotional disturbances. Also to control acute withdrawal
         symptoms in chronic alcoholism.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to oxazepam and other benzodiazepines; psychoses, pregnancy (category C), lactation, children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Older adult and debilitated patients; impaired kidney and liver function; addiction-prone patients; COPD; mental depression.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Anxiety</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1030 mg t.i.d. or q.i.d.<br/><br/><span class="indicationtitle">Acute Alcohol Withdrawal</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1530 mg t.i.d. or q.i.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food if GI upset occurs.</li>
<li>Store in tightly closed container at 15°30° C (59°86° F) unless otherwise specified.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness,</span> dizziness, mental confusion, vertigo, ataxia, headache, lethargy, syncope, tremor, slurred speech, paradoxic reaction (euphoria,
      excitement). <span class="typehead">GI:</span> Nausea, xerostomia, jaundice. <span class="typehead">Skin:</span> Skin rash, edema. <span class="typehead">CV:</span> Hypotension, edema. <span class="typehead">Hematologic:</span> Leukopenia. <span class="typehead">Urogenital:</span> Altered libido. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol,</b> <span class="classification">cns depressants</span>, <span class="classification">anticonvulsants</span> potentiate CNS depression; <b>cimetidine</b> increases oxazepam plasma levels, increasing its toxicity; may decrease antiparkinsonism effects of <b>levodopa;</b> may increase <b>phenytoin</b> levels; smoking decreases sedative and antianxiety effects. <span class="typehead">Herbal:</span> <b>Kava-kava,</b> <b>valerian</b> may potentiate sedation. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Peak:</span> 23 h. <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Primarily excreted in urine, some in feces. <span class="typehead">Half-Life:</span> 28 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Observe older adult patients closely for signs of overdosage. Report to physician if daytime psychomotor function is depressed.</li>
<li>Lab tests: Perform liver function and white blood cell counts on a regular planned basis.</li>
<li> 							Note: Excessive and prolonged use may cause physical dependence. 						</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report promptly any mild paradoxic stimulation of affect and excitement with sleep disturbances that may occur within the
            first 2 wk of therapy. Dosage reduction is indicated.
         </li>
<li>Do not change dose or dose schedule and refrain from using drug to treat a self-diagnosed condition.</li>
<li>Consult physician before self-medicating with OTC drugs.</li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Do not drink alcoholic beverages while taking oxazepam. The CNS depressant effects of each agent may be intensified.</li>
<li>Contact physician if you intend to or do become pregnant during therapy about discontinuing the drug.</li>
<li>Withdraw drug slowly following prolonged therapy to avoid precipitating withdrawal symptoms (seizures, mental confusion, nausea,
            vomiting, muscle and abdominal cramps, tremulousness, sleep disturbances, unusual irritability, hyperhidrosis).
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>